Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.
Lionel Seltz serves as Genomic Vision’s Chief Financial Officer and Executive Board Member, responsible for the oversight of the company’s global finance, corporate development, and strategy implementation.
Lionel joined Genomic Vision in August 2022 from Intrasense, a listed MedTech where he was Group CFO. In that role, Lionel drove finance and funding operations so as structuration of the business. Prior to that, Lionel co-founded a Technology startup returning to France after 6 years in Asia (Singapore and Tokyo) working for IQVIA. During his years with IQVIA (formerly IMS Health), a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry, Lionel was APAC CFO for the Technology division and later responsible for the integration and restructuring of the newly acquired businesses.
Earlier in his career, Lionel notably served as M&A Director and International Development Manager for Cegedim, a listed HealthTech company.
Lionel received his master’s degree in international business from the University of Strasbourg in France and followed several executive courses in corporate finance, strategy and digital marketing at HEC Paris.